School of Social Sciences, Centre for the Development and Evaluation of Complex Interventions for Public Health Improvement (DECIPHer), Cardiff University, Cardiff, UK.
School of Medicine, Centre for Trials Research, Cardiff University, Cardiff, UK.
BMJ Open. 2018 Jun 14;8(6):e020737. doi: 10.1136/bmjopen-2017-020737.
To examine whether young peoples' risk of cannabis, mephedrone and novel psychoactive substances (NPS) use is associated with school substance-misuse policy.
A cross-sectional survey of secondary school students combined with a School Environment Questionnaire and independently coded school substance-misuse policies (2015/6).
66 secondary schools in Wales.
Students aged 11-16 years (n=18 939).
The prevalence of lifetime, past 30-day and daily cannabis use was 4.8%, 2.6% and 0.7%, respectively; lifetime prevalence of mephedrone use was 1.1% and NPS use was 1.5%. Across 66 schools, 95.5% (n=63) reported having a substance-misuse policy, 93.9% (n=62) reported having a referral pathway for drug using students, such that we were insufficiently powered to undertake an analysis. We found little evidence of a beneficial association between lifetime cannabis use and involving students in policy development including student council consultation (OR=1.24, 95% CI 0.89 to 1.73), other student consultation (OR=1.42, 95% CI 0.94 to 2.14) or with the use of isolation (OR=0.98, 95% CI 0.67 to 1.43), with similar results for cannabis use in past 30 days, daily and the lifetime use of mephedrone and NPS. The School Environment Questionnaires found that 39.4% (n=26) schools reported no student involvement in policy development, 42.4% (n=28) reported student council consultation, 18.2% (n=12) used other student consultations and 9.7% (n=3) mentioned isolation. The independently coded content of policies found that no school policy recommended abstinence, one mentioned methods on harm minimisation, 16.1% (n=5) policies mentioned student involvement and 9.7% (n=3) mentioned isolation.
Policy development involving students is widely recommended, but we found no beneficial associations between student involvement in policy development and student drug use. This paper has highlighted the need for further contextual understanding around the policy-development process and how schools manage drug misuse.
探讨青少年使用大麻、苯丙胺和新型精神活性物质(NPS)的风险是否与学校药物滥用政策有关。
对威尔士 66 所中学的中学生进行横断面调查,并结合学校环境问卷和独立编码的学校药物滥用政策(2015 年 6 月)。
威尔士 66 所中学。
年龄在 11-16 岁的学生(n=18939)。
终生、过去 30 天和每天使用大麻的比例分别为 4.8%、2.6%和 0.7%;终生使用苯丙胺的比例为 1.1%,使用 NPS 的比例为 1.5%。在 66 所学校中,95.5%(n=63)报告有药物滥用政策,93.9%(n=62)报告有针对吸毒学生的转介途径,因此我们的研究结果没有足够的效力来进行分析。我们发现,青少年终生使用大麻与参与政策制定(包括学生议会咨询)、其他学生咨询或使用隔离之间几乎没有证据表明存在有益的关联(大麻终生使用的比值比=1.24,95%可信区间 0.89-1.73),对于过去 30 天、每天和终生使用苯丙胺和 NPS 的情况也是如此。学校环境问卷发现,39.4%(n=26)的学校报告没有学生参与政策制定,42.4%(n=28)的学校报告有学生议会咨询,18.2%(n=12)的学校使用其他学生咨询,9.7%(n=3)的学校提到隔离。独立编码的政策内容发现,没有学校政策建议禁欲,有一个政策提到了减少伤害的方法,16.1%(n=5)的政策提到了学生的参与,9.7%(n=3)的政策提到了隔离。
学生参与政策制定被广泛推荐,但我们没有发现学生参与政策制定与学生吸毒之间存在有益的关联。本文强调了进一步了解政策制定过程和学校如何管理药物滥用的需要。